FentaNYL 2 recalled over sterility concerns
- Recall date
- November 9, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals, LLC recalls fentaNYL 2,500 mcg/50 mL in 0.9 % Sodium Chloride Injection (Concentration = 50 mcg/mL) 50 mL Single Dose Syringe, Rx O…
- Recall number
- D-0403-2024
- FDA classification
- Class II
- Brand / firm
- SCA Pharmaceuticals, LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
fentaNYL 2,500 mcg/50 mL in 0.9 % Sodium Chloride Injection (Concentration = 50 mcg/mL) 50 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0202-22, Bar code 70004020022,
Get recall alerts
Free email alert whenever SCA Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals, LLC